In this article, well explore the science behind tirzepatide, break down key clinical trial results, explain how Mounjaro is prescribed and administered, and share practical insights for choosing and monitoring the right patients
When an amylin analogue like cagrilintide is paired with a GLP-1/GIP receptor agonist, the complementary mechanisms appear to produce additive appetite suppression: cagrilintide slows gastric emptying through amylin receptor activation, while tirzepatide simultaneously boosts insulin secretion and reduces glucagon
UV damage
Key Takeaways: What is Atrial Fibrillation
849-P: safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of an optimized dual GLP-1/GIP receptor agonist (BGM0504) in healthy SubjectsA phase ia, randomized, Double-Blind, Placebo-Controlled, ascending dose study